Kobi Altman will serve as acting CFO, replacing Eyal Desheh, who was appointed acting CEO.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has appointed Kobi Altman to serve as Acting CFO, replacing Eyal Desheh, who was appointed acting president and CEO, succeeding Jeremy Levin, who was fired.
Altman (45) has served at Teva since 2006 in various capacities, including as head of global accounting, VP finance and, most recently, as SVP and CFO Americas and head of finance operations. He has a BA in Economics and Accounting and MA in Economics from Bar Ilan University.
Published by Globes [online], Israel business news - www.globes-online.com - on November 7, 2013
© Copyright of Globes Publisher Itonut (1983) Ltd. 2013